Sanofi strengthened the security of its global research and development operations by deploying Evidian Enterprise Single Sign-On (SSO) to simplify and secure access to more than 800 R&D applications. Integrated with Microsoft Active Directory, the solution enabled nearly 18,000 researchers and staff to access multiple Windows, Unix, web, and medical applications using a single secure authentication while supporting biometrics, smartphones, and self-service password reset. It reduced password-related security risks, improved compliance with regulations such as FDA 21 CFR Part 11, and eliminated the need to remember numerous passwords. By simplifying authentication, reducing helpdesk workload, accelerating user onboarding after acquisitions, and providing a scalable foundation for identity

Join for free to read